Robert M Rennebohm

Summary

Affiliation: The Ohio State University
Country: USA

Publications

  1. ncbi Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale
    Robert M Rennebohm
    Division of Pediatric Rheumatolgy, Columbus Children s Hospital and The Ohio State University, 43205, USA
    Arthritis Rheum 51:365-70. 2004
  2. ncbi Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies
    Adam M Huber
    IWK Health Centre and Dalhousie University, 5850 University Avenue, Halifax, Nova Scotia B3J 3G9, Canada
    Arthritis Rheum 50:1595-603. 2004
  3. ncbi Aggressive immunosuppressive treatment of Susac's syndrome in an adolescent: using treatment of dermatomyositis as a model
    Robert M Rennebohm
    Department of Pediatrics, Division of Pediatric Rheumatology, Ohio State University College of Medicine, Columbus, Ohio, USA
    Pediatr Rheumatol Online J 6:3. 2008
  4. ncbi Treatment of Susac's syndrome
    Robert M Rennebohm
    Clinical Pediatrics, Division of Pediatric Rheumatology, Ohio State University, College of Medicine and Public Health, Columbus Children s Hospital, 700 Children s Drive, Columbus, OH 43205, United States
    J Neurol Sci 257:215-20. 2007
  5. ncbi Treatment of Susac's Syndrome
    Robert M Rennebohm
    Robert M Rennebohm, MD Ohio State University, College of Medicine, Columbus Children s Hospital, Rheumatology Division, 700 Children s Drive, Columbus, OH 43205, USA
    Curr Treat Options Neurol 10:67-74. 2008
  6. ncbi Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy
    John O Susac
    Neurology and Neurosurgery Associates, P A, 50 2nd Street S E, Winter Haven, FL 33880 USA
    J Neurol Sci 257:270-2. 2007
  7. ncbi Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats
    Adam M Huber
    Izaak Walton Killam Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Arthritis Rheum 59:352-6. 2008
  8. ncbi Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis
    Adam M Huber
    Division of Pediatric Rheumatology, IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Arthritis Rheum 59:214-21. 2008
  9. ncbi Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies
    Lisa G Rider
    Laboratory of Molecular and Developmental Immunology, Division of Monoclonal Antibodies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Clin Chem 48:1681-8. 2002
  10. ncbi Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity
    April Bingham
    From Office of Clinical Research, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, Maryland 20892 1301, USA
    Medicine (Baltimore) 87:70-86. 2008

Collaborators

  • J O Susac
  • Frederick W Miller
  • Lisa G Rider
  • Carol B Lindsley
  • ANN M contact REED
  • Adam Huber
  • C A Wallace
  • R Egan
  • Terrance P O'Hanlon
  • Alan N Baer
  • I N Targoff
  • Elaine Cochran
  • R M Summers
  • April Bingham
  • Patience H White
  • Andrew H Eichenfield
  • Kathy Amoroso
  • David D Sherry
  • Steven J Klein
  • Alexander Lawton
  • Murray H Passo
  • Perry J Blackshear
  • Simeon Taylor
  • Leslie B Gordon
  • Scott A Vogelgesang
  • Danielle Mercatante Carrick
  • Rafael F Rivas-Chacon
  • Karyl S Barron
  • Stephen W George
  • Michael S Borzy
  • Kristina I Rother
  • Gulnara Mamyrova
  • Harold Marks
  • S Ray Mitchell
  • Ildy M Katona
  • Jerry C Jacobs
  • Paul H Plotz
  • Donald W Scott
  • Lisa Imundo
  • Hillary Haftel
  • Gloria C Higgins
  • Steven R Bauer
  • Laura James-Newton
  • Balu H Athreya
  • Janardan P Pandey
  • Terri H Finkel
  • Christopher T Parker
  • Frederick T Murphy
  • Phillip Gorden
  • John Miller
  • John F Bohnsack
  • Maria D Perez
  • Jorge Laborda
  • Nancy Sebring
  • Donald P Goldsmith
  • Harry L Gewanter
  • Donald A Person
  • Peter N Malleson
  • Judyann Olson
  • Ahalya Premkumar
  • Lawrence S Zemel
  • Gail D Cawkwell
  • Elizabeth Chalom Candell
  • E Arthur
  • Michael Henrickson
  • C Hendrics
  • Olcay Jones
  • Susan H Ballinger
  • Maria Ruiz-Hidalgo
  • Anjelina Pokrovnichka
  • Ilona S Szer
  • Maria Turner
  • David Kleiner
  • Emily Von Scheven
  • Lawrence K Jung
  • C Michael Knee
  • Elif Oral
  • Chihiro Morishima
  • Robert P Sundel
  • Linda I Ray

Detail Information

Publications10

  1. ncbi Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale
    Robert M Rennebohm
    Division of Pediatric Rheumatolgy, Columbus Children s Hospital and The Ohio State University, 43205, USA
    Arthritis Rheum 51:365-70. 2004
    ..To document and evaluate the scores that normal, healthy children achieve when performing 9 maneuvers of the Childhood Myositis Assessment Scale (CMAS)...
  2. ncbi Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies
    Adam M Huber
    IWK Health Centre and Dalhousie University, 5850 University Avenue, Halifax, Nova Scotia B3J 3G9, Canada
    Arthritis Rheum 50:1595-603. 2004
    ....
  3. ncbi Aggressive immunosuppressive treatment of Susac's syndrome in an adolescent: using treatment of dermatomyositis as a model
    Robert M Rennebohm
    Department of Pediatrics, Division of Pediatric Rheumatology, Ohio State University College of Medicine, Columbus, Ohio, USA
    Pediatr Rheumatol Online J 6:3. 2008
    ..The patient's outcome provides evidence for the importance of prompt, aggressive, and sustained immunosuppressive treatment of encephalopathic SS...
  4. ncbi Treatment of Susac's syndrome
    Robert M Rennebohm
    Clinical Pediatrics, Division of Pediatric Rheumatology, Ohio State University, College of Medicine and Public Health, Columbus Children s Hospital, 700 Children s Drive, Columbus, OH 43205, United States
    J Neurol Sci 257:215-20. 2007
    ..We apply lessons learned from study of DM to SS, and offer our current treatment protocol for SS. Since these treatment guidelines are based mainly on anecdotal evidence, they represent only preliminary recommendations...
  5. ncbi Treatment of Susac's Syndrome
    Robert M Rennebohm
    Robert M Rennebohm, MD Ohio State University, College of Medicine, Columbus Children s Hospital, Rheumatology Division, 700 Children s Drive, Columbus, OH 43205, USA
    Curr Treat Options Neurol 10:67-74. 2008
    ..Rituximab is the newest therapy to consider. Treatment should be prompt, aggressive, and sustained to avoid the dreaded residuals of dementia, deafness, and blindness...
  6. ncbi Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy
    John O Susac
    Neurology and Neurosurgery Associates, P A, 50 2nd Street S E, Winter Haven, FL 33880 USA
    J Neurol Sci 257:270-2. 2007
    ..SS is an autoimmune endotheliopathy that requires treatment with immunosuppressants: steroids, cyclophosphamide, and intravenous immunoglobulin, usually in combination. Aspirin is a useful adjunct...
  7. ncbi Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats
    Adam M Huber
    Izaak Walton Killam Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Arthritis Rheum 59:352-6. 2008
    ..The goal of this study was to determine whether alternative scoring methods would shorten the CAT without compromising its measurement characteristics...
  8. ncbi Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis
    Adam M Huber
    Division of Pediatric Rheumatology, IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Arthritis Rheum 59:214-21. 2008
    ..To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new tool to assess cutaneous manifestations of juvenile dermatomyositis (DM), and to explore the clinical meaning of CAT scores...
  9. ncbi Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies
    Lisa G Rider
    Laboratory of Molecular and Developmental Immunology, Division of Monoclonal Antibodies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Clin Chem 48:1681-8. 2002
    ..We evaluated the utility of neopterin and quinolinic acid (QUIN) as surrogate measures of disease activity in juvenile idiopathic inflammatory myopathies (IIMs)...
  10. ncbi Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity
    April Bingham
    From Office of Clinical Research, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, Maryland 20892 1301, USA
    Medicine (Baltimore) 87:70-86. 2008
    ..Further study is warranted to investigate the pathogenesis of acquired LD in patients with DM...